跳至主要内容
临床试验/IRCT20100520003979N9
IRCT20100520003979N9招募中2 期

The evaluation of atypical antipsychotic augmentation with Atomoxetine in the reduction of negative symptoms in patients with Schizophrenia

Ahvaz University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 70 years(—)
性别
All

入选标准

  • Detection of schizophrenia based on the diagnosis of a faculty psychiatrist and an psychiatrist assistant with a clinical interview based on DSM-5
  • Bold negative symptoms( PANSS negative symptom sub-scale score more than 15)
  • Not having liver disease
  • Suffering from the disease for more than a year
  • Age between 18 and 70 years.

排除标准

  • Presence of Depression based on DSM-5 Clinical Interview
  • Presence of Bipolar disorder
  • Pregnant or lactating woman
  • Substance abuse during the last month
  • patients suffering from Attention Deficit Hyperactivity Disorder (ADHD)

研究者

相似试验